(Total Views: 788)
Posted On: 09/16/2020 1:15:28 AM
Post# of 145875
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
The large biotech I worked for explicitly allocated 2% of shares each year to executive comp - new and existing, with some y-t-y variation allowed.
This assumption, along with impacts of other financings, was used in the long range plan in forecasting shares outstanding. I took those presentations to the board and to ratings agencies - neither was offended.
Compare that to what NP is asking, and consider he has to build a "real" company from scratch..
Just my experience, quite a while ago.
This assumption, along with impacts of other financings, was used in the long range plan in forecasting shares outstanding. I took those presentations to the board and to ratings agencies - neither was offended.
Compare that to what NP is asking, and consider he has to build a "real" company from scratch..
Just my experience, quite a while ago.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)